Sree Harsha Mandava

Tulane University

Papers

4

Total Citations

71

H-Index

4

About

Dr. Sree Harsha Mandava is a pioneering urologic surgeon and researcher whose work sits at the intersection of robotic surgery, renal oncology, and biomarker discovery. His primary research focuses on optimizing nephron-sparing surgery—particularly robotic partial nephrectomy for complex tumors—and developing novel methods to assess and mitigate renal injury. Dr. Mandava’s landmark study on robotic partial nephrectomy for clinical stage T1b tumors (30 citations) provided critical intermediate oncologic and functional outcomes, helping to expand the indications for minimally invasive kidney preservation. In a highly cited translational work (23 citations), he demonstrated that urinary cystatin C and NGAL could serve as early, sensitive biomarkers for renal ischemia-reperfusion injury, potentially replacing creatinine in clinical monitoring. His innovative application of dual-color fluorescence structured illumination microscopy for nondestructive kidney cancer diagnosis (13 citations) represents a breakthrough in real-time pathological assessment. Dr. Mandava has also shed light on racial disparities in histology and renal functional outcomes following robotic nephron-sparing surgery (5 citations), highlighting important health equity considerations. His work bridges cutting-edge surgical technique with molecular diagnostics, advancing both the precision and equity of kidney cancer care.

Research Focus

Key Achievements

4
H-Index
4
Papers
71
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Partial Nephrectomy for Clinical Stage T1b Tumors: Intermediate Oncologic and Functional Outcomes
30 citations · 2014
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Tulane University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago